These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 29954929)
1. Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia. Ganzel C; Kharit M; Duksin C; Rowe JM Haematologica; 2018 Oct; 103(10):e489-e490. PubMed ID: 29954929 [No Abstract] [Full Text] [Related]
2. Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD? Aldoss I; Pullarkat V Bone Marrow Transplant; 2019 Jan; 54(1):3-5. PubMed ID: 30446742 [No Abstract] [Full Text] [Related]
3. T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy. Sano H; Mochizuki K; Akaihata M; Kobayashi S; Ohto H; Kikuta A Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781393 [TBL] [Abstract][Full Text] [Related]
4. Philadelphia chromosome-positive acute lymphoblastic leukemia with an e14a3 BCR-ABL1 fusion: The role of molecular monitoring. Crampe M; Langabeer SE; O'Brien D; Ryan E; Bacon CL Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):166-167. PubMed ID: 31158331 [No Abstract] [Full Text] [Related]
5. Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia. Othman T; Li S; Zhang J; Pourhassan H; Agrawal V; Ngo D; Chen J; Farol L; Sahebi F; Sandhu K; Spielberger R; Marcucci G; Forman SJ; Stein AS; Nakamura R; Pullarkat V; Mei M; Aldoss I; Koller P Am J Hematol; 2024 Aug; 99(8):1636-1639. PubMed ID: 38800943 [TBL] [Abstract][Full Text] [Related]
6. Major molecular response prior to allogeneic hematopoietic stem cell transplantation predicts better outcome in adult Philadelphia-positive acute lymphoblastic leukemia in first remission. Cai WZ; Cen JN; Chen J; Chen F; Fu CC; Han Y; Jin ZM; Ma X; Miao M; Qiu HY; Tang XW; Xue SL; Sun AN; Chen SN; Wu DP Bone Marrow Transplant; 2017 Mar; 52(3):470-472. PubMed ID: 28092348 [No Abstract] [Full Text] [Related]
7. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779 [TBL] [Abstract][Full Text] [Related]
8. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Kodama Y; Manabe A; Kawasaki H; Kato I; Kato K; Sato A; Matsumoto K; Kato M; Hiramatsu H; Sano H; Kaneko T; Oda M; Saito AM; Adachi S; Horibe K; Mizutani S; Ishii E; Shimada H Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28084041 [TBL] [Abstract][Full Text] [Related]
9. [Current treatment of philadelphia chromosome-positive acute lymphoblastic leukemia]. Sugiura I Rinsho Ketsueki; 2014 Oct; 55(10):1972-80. PubMed ID: 25297762 [No Abstract] [Full Text] [Related]
10. Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies. O'Dwyer KM; Liesveld JL Best Pract Res Clin Haematol; 2017 Sep; 30(3):184-192. PubMed ID: 29050691 [TBL] [Abstract][Full Text] [Related]
11. [Outcomes of haplotype allogeneic hematopoietic stem cell transplantation in 17 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia]. Zhou J; Zhou H; Zhang R; Wu D Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):170-2. PubMed ID: 24606664 [No Abstract] [Full Text] [Related]
12. Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Is it imperative in the tyrosine kinase inhibitor era? Litzow MR Best Pract Res Clin Haematol; 2018 Dec; 31(4):357-360. PubMed ID: 30466747 [TBL] [Abstract][Full Text] [Related]
13. Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission? Litzow MR Best Pract Res Clin Haematol; 2016 Dec; 29(4):345-350. PubMed ID: 27890258 [TBL] [Abstract][Full Text] [Related]
14. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Fielding AK Hematology Am Soc Hematol Educ Program; 2011; 2011():231-7. PubMed ID: 22160039 [TBL] [Abstract][Full Text] [Related]
15. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study]. Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336 [TBL] [Abstract][Full Text] [Related]
16. Response to ponatinib before hematopoietic stem cell transplantation in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. Yamamoto M; Hori T; Igarashi K; Shimada H; Tsutsumi H Pediatr Int; 2018 Jan; 60(1):85-87. PubMed ID: 29356285 [No Abstract] [Full Text] [Related]
17. Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Cui JK; Xiao Y; You Y; Shi W; Li Q; Luo Y; Jiang L; Zhong ZD J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):693-698. PubMed ID: 29058281 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Caocci G; Vacca A; Ledda A; Murgia F; Piras E; Greco M; Arras M; Atzeni S; Littera R; La Nasa G Biol Blood Marrow Transplant; 2012 Apr; 18(4):652-4. PubMed ID: 22240733 [No Abstract] [Full Text] [Related]
19. Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro". Bachanova V Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S10-S15. PubMed ID: 28760293 [No Abstract] [Full Text] [Related]
20. Imatinib in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia: a viewpoint by Ronan Swords. Swords R Drugs; 2007; 67(17):2655-6. PubMed ID: 18034599 [No Abstract] [Full Text] [Related] [Next] [New Search]